The provision in the economic stimulus bill lifting the cap on drug rebates in Medicaid is on track for implementation in 2024 following final approval of the $1.9tn legislation by the US House of Representatives 10 March. Rebates are currently limited to 100% of a drug’s price, thus the provision means that manufacturers might have to pay rebates exceeding a drug's price.
The implementation date of the provision was pushed back from 2023 to 2024 in the version of the legislation approved...







